Certified by Founder Lodge
Ochre Bio
United Kingdom - Oxford
START UP
1 Disclosed Funding Rounds $30,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally.
Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 11 ,2022 | Series A | $30,000,000 |
BACKED VC
Verge Genomics
Lifeforce Capital
Selvedge Venture
BioAge Labs
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Adronite | $5,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Vizzia | $35,300,400 | (Feb 20, 2026)
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
NuCube Energy | $13,000,000 | (Feb 20, 2026)
